According to a market report by Lucintel, the future of the global transcatheter mitral valve replacement market looks promising with opportunities in the functional mitral regurgitation and degenerative mitral regurgitation markets. The global transcatheter mitral valve replacement market is expected to grow with a CAGR of 15.7% from 2025 to 2031. The major drivers for this market are the increasing prevalence of mitral valve regurgitation, the rising adoption of minimally invasive cardiac procedures, and the growing geriatric population with cardiac disorders.
A more
than 150-page report to understand trends, opportunity and forecast in global transcatheter
mitral valve replacement market to 2031 by type (MitraClip, edwards PASCAL, and
edwards SAPIEN 3), application (functional mitral regurgitation and
degenerative mitral regurgitation), and region (North America, Europe, Asia
Pacific, and the Rest of the World).
Lucintel
forecasts that, within the type category, MitraClip is expected to witness
higher growth over the forecast period.
Within the
application category, functional mitral regurgitation is expected to witness
the highest growth.
Download
sample by clicking on transcatheter
mitral valve replacement market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
Abbott,
Edwards Lifesciences, Medtronic, Boston Scientific, Micro Interventional
Devices, Neovasc, Zhenyi Medical are the major suppliers in the transcatheter mitral valve replacement
market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years.
We are quoted in several publications like the Wall Street Journal, ZACKS, and
the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Hazardous Drug Closed System Transfer Device Market
No comments:
Post a Comment